Connection

Rebecca Bechhold to Receptor, ErbB-2

Back to Details
This is a "connection" page, showing publications Rebecca Bechhold has written about Receptor, ErbB-2.
Rebecca Bechhold
Connection Strength
0.150
Receptor, ErbB-2
  1. A phase II trial of ixabepilone and cyclophosphamide as neoadjuvant therapy for patients with HER2-negative breast cancer: correlation of pathologic complete response with the 21-gene recurrence score. Breast Cancer Res Treat. 2015 Nov; 154(2):299-308.
    View in: PubMed
    Score: 0.122
  2. Neoadjuvant Ixabepilone/Carboplatin/Trastuzumab in HER2-Positive Operable Breast Cancer: A Phase II Trial of the Sarah Cannon Research Institute. Clin Breast Cancer. 2015 Aug; 15(4):251-8.
    View in: PubMed
    Score: 0.028
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.